ArticleAdvances in experimental medicine and biology2026
Innovative Therapeutic Strategies for Chronic Ulcer Healing.
Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic ulcers represent a significant challenge in modern medicine, with profound implications for patients' quality of life, healthcare costs, and clinical management. The complexity of ulcer healing necessitates the development of innovative therapeutic strategies to enhance tissue regeneration and accelerate wound closure. This study investigates the effects of ascorbic acid, arginine, silver sulfadiazine, and colloidal silver on ulcer healing, aiming to elucidate their role in the restoration of skin integrity. A clinical study was conducted on 106 patients, who were divided into an intervention group and a control group. Participants were monitored for up to 75 days, with systematic recording of key clinical healing markers. The findings provide critical insights into the efficacy of these agents in modulating cellular repair mechanisms and promoting faster epithelialization. The proposed therapeutic approaches leverage the synergistic properties of these compounds, which are known for their antioxidative, antimicrobial, and tissue-repairing capabilities. Given the substantial burden of chronic ulcers on healthcare systems and their detrimental impact on patient outcomes, optimizing therapeutic interventions remains a priority. The results of this study contribute to the growing body of evidence supporting alternative and complementary treatments for chronic wound management. By refining clinical protocols and integrating these bioactive agents into standardized treatment regimens, healthcare professionals may improve healing rates, reduce complications, and enhance overall patient care.
Indexed as
Identifiers
41479107What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.